Delivery Order SPE2DB22D9225-SPE2DB25FR8EL
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trikafta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $137,029.08 and a completion date of November 1, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award is for the delivery of Trikafta 100-50-75 mg/75 mg pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $18,526.83 firm fixed-price delivery order was awarded on August 5, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, with a performance completion date of August 6, 2024. DMS Pharmaceutical Group has an existing indefinite delivery contract...
This contract award, SPE2DB20D9127|SPE2DB23FPQC1, is for the delivery of Trikafta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $54,984.87 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award is a delivery order (SPE2DX22FY9PH) valued at $82,463.32, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the procurement of Trikafta, a specialized pharmaceutical product, with a period of performance ending on March 2, 2022. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the pharmaceutical product Trikafta, which is used to treat cystic fibrosis. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the specialized medication Trikafta, with an ultimate completion date of October 17, 2024. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) worth...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the supply of Trikafta, a prescription medication, to support the recurring medical needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Trikafta. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans...
This federal contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price delivery order, valued at $55,580.49, is for the supply of Trikafta, a specialty pharmaceutical product used to treat cystic fibrosis. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that...
This federal contract award, valued at $37,053.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order contract is for the supply of the drug Trikafta, a prescription medication used to treat cystic fibrosis. This award is made under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows the DLA to issue...